Engineering Biomaterials to Model Immune‐Tumor Interactions In Vitro
Advanced Materials · 2024-05 · 36 (19)
DOI: 10.1002/adma.202310637 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 23.02.2024. Verfasst von Arianna Skirzynska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, ON, M5S 3E5, Canada. Hauptthemen laut MEDLINE: Biocompatible Materials, Neoplasms, Tumor Microenvironment, Tissue Engineering. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada Herzberg, Natural Sciences and Engineering Research Council of Canada Discovery.
Abstract (Originalsprache)
Engineered biomaterial scaffolds are becoming more prominent in research laboratories to study drug efficacy for oncological applications in vitro, but do they have a place in pharmaceutical drug screening pipelines? The low efficacy of cancer drugs in phase II/III clinical trials suggests that there are critical mechanisms not properly accounted for in the pre‐clinical evaluation of drug candidates. Immune cells associated with the tumor may account for some of these failures given recent successes with cancer immunotherapies; however, there are few representative platforms to study immune cells in the context of cancer as traditional 2D culture is typically monocultures and humanized animal models have a weakened immune composition. Biomaterials that replicate tumor microenvironmental cues may provide a more relevant model with greater in vitro complexity. In this review, the authors explore the pertinent microenvironmental cues that drive tumor progression in the context of the immune system, discuss how these cues can be incorporated into hydrogel design to culture immune cells, and describe progress toward precision oncological drug screening with engineered tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, ON, M5S 3E5, Canada.
- Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, 160 College St, Toronto, ON, M5S 3E1, Canada.
- Institute for Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON, M5S 3G9, Canada.
- Department of Chemistry, University of Toronto, 80 College Street, Toronto, ON, M5S 3H4, Canada.
ORCID-Profile: Arianna Skirzynska, Molly S Shoichet
Förderung
- Natural Sciences and Engineering Research Council of Canada Herzberg
- Natural Sciences and Engineering Research Council of Canada Discovery
Zitieren
APA
Skirzynska, A., Xue, C., & Shoichet, M. S. (2024). Engineering Biomaterials to Model Immune‐Tumor Interactions In Vitro. Advanced Materials, 36(19). https://doi.org/10.1002/adma.202310637
Vancouver
Skirzynska A, Xue C, Shoichet MS. Engineering Biomaterials to Model Immune‐Tumor Interactions In Vitro. Advanced Materials. 2024;36(19). doi:10.1002/adma.202310637
BibTeX
@article{Skirzynska2024,
author = {Skirzynska, Arianna and Xue, Chang and Shoichet, Molly S},
title = {Engineering Biomaterials to Model Immune‐Tumor Interactions In Vitro},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {19},
doi = {10.1002/adma.202310637}
}
EUVIMED